These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 6203684

  • 1. Comparative effects of inhaled isoproterenol and vasoactive intestinal peptide on histamine-induced bronchoconstriction in human subjects.
    Altiere RJ, Küng M, Diamond L.
    Chest; 1984 Jul; 86(1):153-4. PubMed ID: 6203684
    [No Abstract] [Full Text] [Related]

  • 2. [Effects of vasoactive intestinal polypeptide (VIP) on histamine or prostaglandin F-2alpha-induced bronchoconstriction (author's transl)].
    Hara N, Yosida T, Said SI.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1978 Dec; 16(11):840-5. PubMed ID: 739695
    [No Abstract] [Full Text] [Related]

  • 3. Vasoactive intestinal peptide causes bronchodilatation and protects against histamine-induced bronchoconstriction in asthmatic subjects.
    Morice A, Unwin RJ, Sever PS.
    Lancet; 1983 Nov 26; 2(8361):1225-7. PubMed ID: 6139572
    [Abstract] [Full Text] [Related]

  • 4. The effect of inhaled vasoactive intestinal peptide on bronchial reactivity to histamine in humans.
    Barnes PJ, Dixon CM.
    Am Rev Respir Dis; 1984 Aug 26; 130(2):162-6. PubMed ID: 6465669
    [Abstract] [Full Text] [Related]

  • 5. VIP and asthma.
    Barnes PJ, Bloom SR, Dixon CM.
    Lancet; 1984 Jan 14; 1(8368):112. PubMed ID: 6140418
    [No Abstract] [Full Text] [Related]

  • 6. Potentiation of the bronchoprotective effects of vasoactive intestinal peptide, isoprenaline, and theophylline against histamine challenge in anaesthetised guinea pigs by adrenomedullin.
    Kanazawa H, Kawaguchi T, Fujii T, Shoji S, Hirata K, Kudoh S, Kurihara N, Yoshikawa J.
    Thorax; 1996 Dec 14; 51(12):1199-202. PubMed ID: 8994515
    [Abstract] [Full Text] [Related]

  • 7. Comparison of vasoactive intestinal peptide and isoproterenol relaxant effects in isolated cat airways.
    Altiere RJ, Diamond L.
    J Appl Physiol Respir Environ Exerc Physiol; 1984 Apr 14; 56(4):986-92. PubMed ID: 6725078
    [Abstract] [Full Text] [Related]

  • 8. [The nonadrenergic noncholinergic system in the regulation of bronchial tonus].
    Gianotti A, Bottino G, Moscatelli P.
    Minerva Med; 1986 Dec 22; 77(49-50):2299-306. PubMed ID: 3808386
    [Abstract] [Full Text] [Related]

  • 9. Adenosine-induced bronchoconstriction in asthma. Role of parasympathetic stimulation and adrenergic inhibition.
    Mann JS, Cushley MJ, Holgate ST.
    Am Rev Respir Dis; 1985 Jul 22; 132(1):1-6. PubMed ID: 2990269
    [Abstract] [Full Text] [Related]

  • 10. Effect of beta adrenergic agents on in vitro histamine release and bronchial challenge responses.
    Rosenthal RR.
    Chest; 1978 Jun 22; 73(6 Suppl):977-9. PubMed ID: 79467
    [No Abstract] [Full Text] [Related]

  • 11. Neuropeptide- and capsaicin-induced histamine release in skin monitored with the microdialysis technique.
    Huttunen M, Harvima IT, Ackermann L, Harvima RJ, Naukkarinen A, Horsmanheimo M.
    Acta Derm Venereol; 1996 May 22; 76(3):205-9. PubMed ID: 8800300
    [Abstract] [Full Text] [Related]

  • 12. Effect of infused vasoactive intestinal peptide on airway function in normal subjects.
    Palmer JB, Cuss FM, Warren JB, Blank M, Bloom SR, Barnes PJ.
    Thorax; 1986 Sep 22; 41(9):663-6. PubMed ID: 3787552
    [Abstract] [Full Text] [Related]

  • 13. Endogenous broncho-active substances and their antagonism.
    Collier HO.
    Adv Drug Res; 1970 Sep 22; 5():95-107. PubMed ID: 4395356
    [No Abstract] [Full Text] [Related]

  • 14. Proceedings: Anaphylactic release of prostaglandins, slow-reacting substance, and histamine, and its modification by sympathomimetics.
    Liebig R, Peskar B, Bernauer W.
    Naunyn Schmiedebergs Arch Pharmacol; 1974 Sep 22; 282(Suppl):suppl 282:R58. PubMed ID: 4135775
    [No Abstract] [Full Text] [Related]

  • 15. [Effect of traxanox sodium on SRS-A release in bronchial and peritoneal anaphylaxis].
    Terasawa M, Imayoshi T, Goto K.
    Nihon Yakurigaku Zasshi; 1983 Jul 22; 82(1):93-101. PubMed ID: 6194083
    [Abstract] [Full Text] [Related]

  • 16. Bronchial responsiveness to inhaled histamine and isoprenaline in patients with airway obstruction.
    Benson MK.
    Thorax; 1978 Apr 22; 33(2):211-3. PubMed ID: 663881
    [Abstract] [Full Text] [Related]

  • 17. Effect of an inhaled neutral endopeptidase inhibitor, phosphoramidon, on baseline airway calibre and bronchial responsiveness to bradykinin in asthma.
    Crimi N, Polosa R, Pulvirenti G, Magrì S, Santonocito G, Prosperini G, Mastruzzo C, Mistretta A.
    Thorax; 1995 May 22; 50(5):505-10. PubMed ID: 7597662
    [Abstract] [Full Text] [Related]

  • 18. [Effect of verapamil on the action of isoproterenol].
    Zou HL, Wei EQ, Yang W, Bian RL.
    Yao Xue Xue Bao; 1985 Mar 22; 20(3):173-7. PubMed ID: 2416188
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.